Sir:
As has previously been reported, 6'-N-methylation1.2) and 6'-C-alkylation3) of kanamycins leads to derivatives which have good antibacterial activity against resistant strains producing 6'-N-acetyltransferases [AAC(6')]. In this paper, we report the preparation and antibacterial activity of 6'-N-formimidoylamikacin
(1), 6'-Nacetimidoylamikacin (2) and 6'-N-formimidoyldibekacin (3) .
Compounds 1 and 2 were synthesized starting from 6'-N-benzyloxycarbonylkanamycin (4)1.4) through 3, 3",4"'-tri-N-tert-butoxycarbonylamikacin (9).
The selective protection at the 3-amino group of 4 with tert-butyl S-4,6-dimethylpyrimid-2-ylthiocarbonate (Boc-S reagent, Kokusan Chemical Works) in DMSO by the method of zinc-chelationb) gave 6'-N-benzyloxycarbonyl-3-N-tert-butoxycarbonylkanamycin (5) Resistance: a) AAD(4'), b) AAC(6'), °) APH(3')-I, d) AAD(2"), e) APH(3')-II, 1) AAC(3), g) AAC(2'), h) APH(3')-III , ') permeability. * Concentrations are shown as the free bases . Minimum inhibitory concentrations of compounds 1, 2 and 3 on Mueller-Hinton agar plates are shown in Table 1 in comparison with those of amikacin and dibekacin. All these compounds are more active than parent antibiotics against resistant strains, Escherichia coli K-12 R-5 and Pseudomonas aeruginosa GN315 which produced AAC(6'). Generally however, the 6'-N-amidination slightly decreased the antibacterial activity of kanamycins. 
